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Abstract:  Coumarin  derivative  1,  5,7-dihydroxy-6-(3-methyl-1-butyryl)-4-phenyl-
chromen-2-one,  has  been  reported  to  possess  radical  scavenging  activity  and  DNA 
protection.  We  have  synthesized  a  series  of  coumarins  with  structural  modifications  at 
positions  C4,  C5,  C6  and  C7  and  evaluated  them  for  their  anti-UVC  properties.  
Coumarin  7,  6-benzoyl-5,6-dihydroxy-4-phenyl-chromen-2-one,  was  found  to  have  the 
most  potent  activity  in  protecting  porcine  γ-crystallin  against  UVC  insults.  Results  of 
fluorescence  assays  indicated  that  compound  7  was  capable  of  decreasing  the  loss  of 
intensity while lens crystallins and DNA PUC19 were irradiated with UVC. Presence of 
compound 7 decreased hydroxyl radical levels determined by probe 1b and the free iron 
concentrations  determined  by  Ferrozine  reagent.  The  chelation  assay  showed  that 
compound  7  was  chelated  to  metal  via  6-CO  and  5-OH  on  the  benzopyrone  ring.  The 
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observed protective effects of compound 7 towards crystallins from insults of UVC and free 
radicals may be due to its iron-chelating activity and its peak absorption at 254 nm.  
Keywords: irradiation; anti-cataract; coumarin; γ-crystallin; iron-chelation 
 
1. Introduction  
Solar radiation can be divided into five regions in increasing order of wavelengths: ultraviolet UVC, 
UVB, UVA, visible range, and infrared range. Among these radiations, UVC and UVB are responsible 
for  photochemical  reactions.  UVA,  visible-range,  and  infrared-range  radiation  were  traditionally 
thought to be less damaging. UV-induced oxidative damage is highly related to cataractogenesis [1,2]. 
Compounds with anti-UV properties can be used as anti-cataract agents. Coumarin derivatives were 
reported to protect rabbit corneal-derived cells (SIRCs) from UVB-induced oxidative damage [3].
 
Coumarins are a class of phenolic substances commonly found in plants, fungi, and bacteria [4]. 
Structures  of  these  compounds  consist  of  a  benzene  moiety  fused  to  an  α-pyrone.  The  structural 
diversity found in this family of compounds can be classified into different categories, from coumarins 
to  polycyclic  coumarins,  such  as  furocoumarins  and  pyranocoumarins.  This  diversity  leads  to  
multiple  pharmacological  activities;  natural  and  synthetic  coumarins  have  anti-inflammatory  [5,6], 
antimicrobial  [6,7],  antiviral  [6,8],  anticarcinogenic  [6,9],  anticoagulant  [6,10],  and  antioxidant 
activities [6,10]. Generally speaking, their mechanisms of action are not well understood. 
Among  activities  of  coumarin  derivatives,  their  antioxidant  properties  have  garnered  attention  
due to their potential applications. Compounds containing the moiety of coumarin (1,2-benzopyrone, 
2H-1-benzopyran-2-one, 2) were shown to possess antioxidant activity [11–20]. Many different types 
of antioxidant activity of coumarins were investigated in various biological systems, but it was difficult 
to  determine  a  structure-activity  relationship  [5,6,11,21].  The  scavenging  capacities  of  coumarins 
against various free-radical types were investigated. Those results implied that compounds with phenolic 
hydroxyl groups are thought to possess antioxidant activities. A hydroxyl group on an aromatic ring 
structure  can  carry  out  the  single-electron  reduction  of  a  free  radical;  therefore,  compounds  with 
phenolic hydroxyl groups are good radical scavengers. 
The  eyes  are  constantly  exposed  to  reactive  oxygen  species  (ROS)  induced  by  UV  light  [22].  
A  previous  report  showed  that  corneal  and  tear  fluids  possess  an  elaborate  antioxidant  defense  
system [23]. However, UV light can pass through the cornea and enter the lens. UV irradiation is one 
of the significant risk factors in cataractogenesis. Chemical modifications or oxidation of lens proteins 
may  also  contribute  to  the  emergence  of  opacities.  Eye  drops  containing  antioxidants  such  as 
tropicamide, phenylephrine, flurbiprofen, and tobramycin are also given preoperatively [24]. In recent 
years, the protective effects of compounds against UV-induced oxidative damage of the eye  were 
investigated [3,25,26]. It was shown that UV irradiation can cause turbidity of γ-crystallin [27,28]. 
Although the detailed mechanism of this phenomenon remains vague, it is believed to be related to 
ROS induced by UV light. The focus on the antioxidant activities of coumarin derivatives brought our 
attention to cataracts, which are thought to be correlated with oxidative stress [29–34].
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Previously, we showed that coumarin 1 (Chart 1) possess anti-inflammatory, antioxidant activities, 
and  the  pUC-19  plasmids  co-incubated  in  the  presence  of  coumarin  1  exhibited  less  DNA  strand 
damage and most of the plasmids were in the supercoiled form [20]. Those results demonstrated that 
our  6-acyl-4-aryl-alkyl-5,7-dihydroxycoumarins  have  the  ability  to  scavenge  the  hydroxyl  radical 
under  Fenton reaction  conditions. Since phenolic compounds are well-known antioxidants, we are 
interested in examining the antioxidative effects of the compounds where (i) a phenolic moiety is 
attached to the 6-acyl position of 6-acyl-4-phenyl-5,7-dihydroxycoumarin; (ii) the hydroxyl group of 
6-benzoyl is replaced with methyl or hydrogen; and (iii) 5- and 7-hyroxyl groups are present on the 
coumarin ring. Therefore, here we aimed to established an in vitro anti-UVC assay and use it to screen 
for the most potent anti-UVC radiation compound from the library of synthetic coumarin derivatives  
3–11  (Chart  1).  This  compound  was  further  investigated  towards  crystallins  and  DNA  protection,  
and  the  involvement  of  iron-chelation  activity  was  then  further  examined  by  Ferrozine  assay  and  
NMR spectroscopy. 
Chart 1. Structures of coumarin derivatives. 
 
2. Results and Discussion  
2.1. Chemistry 
Coumarin is a flavonoid, which is a natural constituent of many plants and essential oils. Coumarins 
from plants are derivatives of cinnamic acid with a benzo-α-pyrone skeleton [35]. They are classically 
synthesized by the Perkin, Pechmann, or Knoevenagel reactions [6]. Pechmann condensation utilizes a 
phenol  and  carbozylic  acid  or  ester  for  the  coumarin  synthesis.  We  synthesized  several  coumarin 
derivatives using this method [20,36]. Herein, we followed a similar strategy to synthesize most of 
coumarin derivatives (Scheme 1). Int. J. Mol. Sci. 2011, 12                       
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Scheme  1.  Synthesis  of  coumarin  derivatives.  Conditions:  a:  12,  ethyl  benzoylacetate, 
trifluoroacetic acid, reflux, 40%; b: p-anisoyl chloride, AlCl3, nitrobenzene, 60 °C, 3 h, 
16%; c: p-cyanobenzoyl chloride, AlCl3, nitrobenzene, 60 °C, 3 h, 15%; d: 12, benzoyl 
chloride, AlCl3, nitrobenzene, 60 °C, 3 h, 15%; e: 15, p-toluoyl chloride, AlCl3, nitrobenzene, 
60 °C, 3 h, 36%; f: 14, ethyl benzoylacetate, glacial HOAc, conc. H2SO4, 15%; g: sodium 
acetate, acetic anhydride, 160 °C, 1 h, 86%; h: 14, ethyl propionylacetate, glacial HOAc, 
conc.  H2SO4,  27%;  i:  13,  ethyl  benzoylacetate,  glacial  HOAc,  conc.  H2SO4,  60%;  
j: 1.5 N NaOH, THF, reflux 1 h, 75%; k: oxalyl chloride, THF, DMF; l: phenol, NaH, THF; 
m: 5 mol% AuCl3, AgOTf, 70%. 
 
2.2. Biological Results  
2.2.1. Turbidity Assay of γ-Crystallin and Comparison of Anti-UVC Activity 
Previously,  UVC  irradiation  to  induce  turbidity  of  γ-crystallin  was  applied  to  measure  the 
chaperone  activity  of  lens  α-crystallin  [24,25].  Lens  γ-crystallin  was  correlated  to  cataracts  and Int. J. Mol. Sci. 2011, 12                       
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demonstrated in a mouse model [37]. Formation of amyloid fibrils in vitro from partially unfolded 
intermediates of human γ-crystallin was investigated [38]. Amongst the lens crystallins, γ-crystallins 
are particularly sensitive to oxidation, because of their high amounts of Cys and Met residues [39]. 
Therefore,  we  chose  γ-crystallins  as  the  reported  proteins  for  our  assays.  Compounds  that  protect  
γ-crystallins  from  damage  by  UVC  irradiation  can  be  anti-cataract  agents.  Hydroxycoumarins  
were previously shown to have antioxidant activities [11,20,21]. They are believed to act like classic 
phenol- or quinol-based antioxidants which can carry out the single-electron reduction of a free radical. 
Compound  3  (5,6-dihydroxy-6-(4-hydroxybenzoyl)-4-phenyl-2H-chromen-2-one)  was  dissolved  in 
DMSO to create a stock solution which was then added to the sample solution to achieve a maximum 
final DMSO concentration of 10% (v/v). The sample solutions of 200 µL each were exposed to a UV 
lamp (254 nm), and turbidity was measured before and after UV irradiation. For each condition, four 
sample solutions were used in the experiment. The results indicated that compound 3 can effectively 
suppress the turbidity induced by UV irradiation (Figure 1A). After UV irradiation, the sample with 10% 
DMSO showed a slight increase in turbidity, whereas the sample with vitamin C (1 mM) showed a 
delayed increase of turbidity. It was obvious that vitamin C possesses statistically significant less anti-
UV  activity  than  compound  3  at  4  h  observation  (P  <  0.05).  SDS-PAGE  analysis  showed  that  
γ-crystallin was effectively protected by compound 3 (Figure 1B), whereas the samples with vitamin C 
and DMSO only (10%) were photo-degraded after 4 h of UV irradiation. 
Figure 1. Turbidity assay of compound 3 under UV irradiation. (A) Porcine γ-crystallins, 
with  or  without  compound  3,  were  irradiated  by  UV  (254  nm),  and  the  turbidity  was 
measured at 630 nm by ELISA reader. Solvent, DMSO, and ascorbic acid were used as 
controls. The bars denote ranges of variation from four measurements; (B) SDS-PAGE of 
porcine  γ-crystallin  before  and  after  UV  irradiation  (4  h)  in  various  conditions.  
Lane 1: γ-crystallin before UV irradiation. Lane 2: γ-crystallin after UV irradiation. Lanes 
3, 4, and 5: γ-crystallin with compound 3 (0.5, 1.0, and 2.0 mM, respectively) after UV 
irradiation. Lane 6: γ-crystallin with ascorbic acid (1.0 mM) after UV irradiation. Lane 7: 
γ-crystallin with DMSO (10%) after UV irradiation. M: markers. The masses of markers  
are 116.0 kDa, 66.2 kDa, 45.0 kDa, 35.0 kDa, 25.0 kDa, 18.4 kDa and 14.4 kDa from the 
top to bottom of the gel. 
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In  order  to  study  the  structural  activity  relationship,  various  compounds  were  compared  in  the  
same activity assay (Table 1). Due to differences in the solubilities and colors of these compounds,  
the  change  in  turbidity  was  used  in  this  assay.  Porcine  γ-crystallins  with  or  without  compounds  
were irradiated by UVC (254 nm), and the turbidity was measured at 630 nm on an ELISA reader.  
The changes in turbidity after 4 h of UVC irradiation were recorded, and a sample of only porcine  
γ-crystallin, without other compounds, was used as a blank. The results indicated that potency ranking 
of anti-UVC activity was as follows: 7 > 4 = 6 > 3 > 9 > 10 > 11 > 8 > 2 > 5 (Table 1). Coumarin (2) 
showed  20%  suppression  of  turbidity,  and  SDS-PAGE  showed  it  had  poor  protective  activity. 
Compounds 3–7 respectively showed 66%, 103%, 12.5%, 99.9%, and 116% suppression of turbidity. 
SDS-PAGE  also  indicated  that  compounds  3,  4,  6,  and  7  showed  good  protective  activities.  
Compound  3  possesses  three  phenolic  hydroxyl  groups,  but  it  showed  only  66%  suppression  of 
turbidity. Compound 4 was more potent than compound 3 indicating that the 6-p-methylbenzoyl group 
is more potent than the 6-p-hydroxybenzoyl group. Compound 7 showed the best protective activity 
among  them.  The  6-p-hydroxybenzoyl  group  was  less  potent  than  the  6-benzoyl  group  when 
comparing compounds 3 and 7. Compound 5 showed only 12.5% suppression of turbidity, and SDS-
PAGE showed that it had less protective activity, which indicated that the 5-hydroxyl group may play 
an important role in protective activity. Substitution of the 5,7-dihydroxyl groups in compound 7 with  
O-acetyl  groups  (compound  6)  did  not  show  significant  effects  in  augmenting  protective  activity. 
However, compound 6 showed less solubility in the buffer. The result indicated that compound 7 was 
the most potent compound in this study. 
Table 1. Optical density (OD) at 4 h observations. Turbidity assay of various coumarin 
derivatives under UV irradiation at a concentration of 0.5 mM. Porcine γ-crystallins, with 
or without co-incubation with test compounds, were irradiated by UV (254 nm) for four 
hours, and the turbidity was measured at 630 nm with an ELISA reader and expressed as 
mean ± standard derivation.  
cpd no.  2  3  4  5  6 
OD  0.636 ± 0.041  0.193 ± 0.043  −0.031 ± 0.008  0.698 ± 0.150  0.0003 ± 0.074 
cpd no.  7  8  9  10  11 
OD  −0.041 ± 0.012  0.502 ± 0.012  0.284 ± 0.035  0.364 ± 0.018  0.406 ± 0.032 
Previous reports have indicated that water irradiated by UVC forms free radicals [40,41]. It was 
reported  that  ascorbic  acid  exhibits  potent  free  radical-scavenging  activity  and  was  used  as  the  
control  [42].  Ascorbyl  radicals  are  long-lived  free  radicals  which  make  vitamin  C  a  good  radical 
scavenger [43]. The sample with vitamin C (1 mM) showed a delayed increment in turbidity after 
UVC irradiation. A high concentration of vitamin C can protect γ-crystallin from photodegradation by 
UVC. Hence, photodegradation of γ-crystallin can be correlated to free radical reactions. 
2.2.2. Evaluation of the Substitution Groups 
An additional interesting aim of the investigation was to determine the structure-activity relationship 
of coumarin derivatives. From the above study, it was shown that substitution of a 6-benzoyl group in 
compound  7  affected  its  activity.  Therefore,  by  means  of  the  Pechmann  reaction,  we  synthesized Int. J. Mol. Sci. 2011, 12                       
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compound 8 which does not contain a 6-benzoyl  group (Scheme 1). The anti-UVC activity assay 
showed that compound 7 was more potent than compound 8. Compound 7 showed 94% suppression of 
turbidity, whereas compound 8 showed only 36% suppression of turbidity. SDS-PAGE showed that 
both compounds could protect against γ-crystallin degradation (data not shown). Hence, we concluded 
that the 6-benzoyl group promoted anti-UVC activity. This result may have been due to the addition of 
the 6-benzoyl group helping to stabilize free radicals at position 6 when phenolic hydroxyl groups 
carry out the single-electron reduction. 
To evaluate the function of the 4-phenyl group of compound 7, compound 9 was synthesized in a 
similar  way  as  compound  8  (Scheme  1).  The  4-phenyl  group  was  changed  to  a  4-ethyl  group  in 
compound 9. The results of the activity assay revealed that compound 7 showed 89.3% suppression of 
turbidity, whereas compound 9 showed only 54% suppression of turbidity. It was demonstrated that 
compound 7 was more potent than compound 9. SDS-PAGE showed that both compounds can protect 
against γ-crystallin degradation (data not shown). The 4-phenyl group also played a role in promoting 
the anti-UVC activity of compound 7. It was proposed that the addition of a 4-phenyl group would 
enhance the resonance effects of coumarin derivatives. 
Table 1 shows the comparisons of all tested coumarin derivatives. Results show that coumarin 
possesses poor anti-UVC activity. The addition of hydroxyl groups to coumarin derivatives greatly 
improved the anti-UVC activities of these compounds. Compound 5 showed poor anti-UVC activity, 
indicating  that  the  5-hydroxyl  group  may  play  an  important  role  in  the  activity  of  compound  7. 
Therefore,  we  synthesized  compounds  10  and  11  (Scheme  1)  to  investigate  the  influence  of  the 
phenolic hydroxyl group. The anti-UVC activity assay of compounds 8, 10, and 11 demonstrated that 
both  compound  10  and  11  possessed  poor  activity.  Compound  8  showed  77.8%  suppression  of 
turbidity, while compounds 10 and 11 respectively showed only 68.7% and 35.8% suppression. The 
SDS-PAGE analysis also revealed that compounds 10 and 11 possessed poorer protective activities 
(data not shown). Compound 11 exhibited slightly higher anti-UVC activity than coumarin, which 
indicates that the 5,7-dihydroxyl groups are important in this activity assay. However, compared to 
compound 11, the activity of compound 10 was lower by about 10%, but SDS-PAGE showed that  
γ-crystallin was severely degraded. Comparing compounds 10 and 5 showed that the 5-p-cyanobenzoyl 
group of compound 5 led to the poor activity. The phenolic hydroxyl group improved the anti-UVC 
activity of the compound. It should be noted that hydroxyl groups also improved the solubility of the 
coumarin derivatives in the water-based buffer. 
2.2.3. Protection of DNA 
It was demonstrated that compound 7 possessed the best anti-UVC activity among these coumarin 
derivatives. However, UVC irradiation damages both proteins and DNA. UVC irradiation may damage 
the DNA of cells. The outside surface of the lens is a layer of lens epithelial cells. UVC damage to lens 
epithelial cells may lead to acute UVC cataractogenesis [44]. Therefore, the ability of compound 7 to 
protect DNA from UVC damage was tested (Figure 2). Supercoiled DNA (PUC19 plasmid) irradiated 
by  UVC  (254  nm)  became  linear  DNA  and  then  photodegraded.  The  addition  of  compound  7 
prevented the supercoiled DNA from photodegradation. After 30 min of irradiation, a portion of the 
supercoiled DNA was preserved in the presence of compound 7, while all DNA had become linear in Int. J. Mol. Sci. 2011, 12                       
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the presence of vitamin C. It was shown that the UVC-protective property of compound 7 is more 
potent than that of vitamin C. 
Figure  2.  Activities  of  compound  7  and  vitamin  C  in  protecting  DNA  from 
photodegradation by UV. (A) Plasmid DNA (PUC19) was broken and then degraded under 
UV irradiation. Lane 1, supercoiled DNA without UV irradiation; lanes 2–6, DNA after 
UV irradiation for 30, 60, 90, 120, and 150 min, respectively; (B) Plasmid DNA incubated 
with compound 7 (1 mM) showed that some fraction of DNA was preserved under UV 
irradiation; (C) Plasmid DNA incubated with vitamin C (1 mM) showed that most DNA 
became the linear form and then degraded under UV irradiation. 
 
2.2.4. Compound 7 Protects Porcine Lens Proteins from Oxidative Damage by Hydroxyl Radicals 
In the abovementioned discussion on the mechanism of compound 7’s anti-UVC activity, we have 
assumed  that  compound  7  possesses  free  radical-scavenging  properties.  Therefore,  we  tested  if 
compound 7 can protect lens crystallins from the Fenton reaction (Figure 2). Although all amino acid 
residues in the protein chain are susceptible to modification by the hydroxyl radical, tryptophan is the 
most vulnerable amino acid. In our previous report, the intrinsic fluorescence of lens crystallins was 
used as an index of the effectiveness of the tested compound [45]. Herein, we showed that compound 7 
protected  lens  crystallins  in  a  dose-dependent  manner  (Figure  3).  The  solvent,  DMSO,  had  no 
protective function. It was demonstrated that compound 7 is a free radical scavenger and can protect 
crystallins.  However,  the  commonality  between  UV  irradiation  and  the  Fenton  reaction  was  not 
provided. It is known that hydroxyl radicals are produced during UV-light dissociation of H2O2. Hence, 
we  tested  if  UV  irradiation  increased  H2O2  in  solution.  A  sensitive  probe  for  H2O2  was  used  to 
evaluate H2O2 produced by UV irradiation [46]. These results indicated that UV irradiation produced 
H2O2 and showed some commonality with the Fenton reaction (data not shown). 
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Figure 3. Free radical-scavenging activity. Porcine crystallins were subjected to oxidative 
stress by Fenton solutions with/without the protection of compound 7. Negative changes 
indicate the loss of fluorescence intensity of tryptophan of lens crystallins. The protective 
activity of compound 7 was concentration-dependent. 
 
2.3. Iron-Chelating Activity 
Although compound 7 with phenolic hydroxyl groups showed free radical-scavenging properties, 
there are other possibilities in preventing the Fenton reaction. A previous report indicated that the 
chelator is capable of binding ferrous and ferric iron, reducing concentrations of Fe(II) and Fe(III) in 
solution,  and  thus  alleviating  the  Fenton  reaction  [47].  In  view  of  its  chemical  structure,  results 
suggested that  compound 7  can chelate  Fe(II).  The chelation assay showed that compound 7 was 
capable of binding ferrous iron (Figure 4). To further confirm this property, 
1H NMR titration studies 
were performed to identify the likely site of iron binding on compound 7. A diamagnetic metal ion, 
Zn
2+, was used as the probe for Fe
2+ [48]. Figure 5 shows the 1D-NMR spectrum of compound 7 in the 
presence  and  absence  of  ZnAc.  As  Zn
2+  was  added,  little  change  was  observed  in  most  of  the 
compound 7 peaks; however, the H8 proton peak showed a slight upfield shift (of ca. 0.03 ppm).  
H8 resonance (shifted and broadened) was observed by 1:2 stoichiometric Zn complexation indicating 
that Zn is chelated to 6-CO and 5-OH on the benzopyrone ring. Since the H8 proton experienced a 
small  change  of  an  upfield  shift,  it  is  unlikely  to  have  been  chelated  to  6-CO  and  7-OH  on  the 
benzopyrone ring. Due to the similar coordination properties of Fe
2+ and Zn
2+, it is reasonable to 
suggest that Fe
2+ was chelated at the same site as Zn
2+. 
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Figure  4.  Iron-chelating  activity  of  compound  7.  Comparative  analyses  of  ferrous  
ion-chelating potency with various concentrations of compound 7, and positive controls 
(30 mM of catechin or deferoxamine) were performed to determine their ability to complex 
with  ions.  The  percentage  of  the  chelating  effect  was  calculated  using  the  following 
equation: [1 − (absorbance of a sample at 562 nm)/(absorbance of the control, without 
tested a sample or positive control, at 562 nm)]/100. 
 
Figure  5.  1D-nuclear  magnetic  resistance  (NMR)  spectrum  of  5  mM  of  compound  7 
without  and  in  the  presence  of  ZnAc  in  50  mM  Tris-HCl  at  pH  7.2  (50/50,  v/v,  
DMSO-d6/D2O-Tris-HCl): (a) at a 1: 0; (b) at a 1: 0.5; (c) at a 1: 1; and (d) at a 1: 2  
Zn equivalent. 
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3. Experimental Section  
3.1. General Experimental Conditions 
Melting points were taken in a capillary tube using a MEL-TEMP II melting-point apparatus by 
Laboratory  Devices  (CA,  USA).  Nuclear  magnetic  resonance  (NMR)  spectra  were  recorded  on  a 
Bruker DMX-500 FT-NMR spectrometer (Madison, WI, USA); chemical shifts were recorded in parts 
per million downfield from Me4Si. IR spectra were determined with a Perkin-Elmer 1760-X FT-IR 
spectrometer (Massachusetts, USA). Mass spectra were recorded on Jeol JMS-D300 (Tokyo, Japan) 
and FINNIGAN TSQ-46C mass spectrometers (Thermo scientific, USA); HRMS was obtained with a 
Jeol JMS-HX110 spectrometer. TLC was performed on Merck (Art. 5715) silica gel plates (Darmstadt, 
Germany) and visualized under UVC light (254 nm). Flash column chromatography was performed 
with Merck (Art. 9385) 40–63 µm silica gel 60. 
3.2. Preparation of Coumarin Derivatives 3–11 
Synthesis of coumarins 3–5, 7, and 9 were reported by our laboratory [20,36]. Acetylation of the 
phenolic  hydroxyl  group  of  coumarin  derivative  7  was  yielded  coumarin  derivative  6.  Resorcinol 
treated  with  ethyl  benzoylacetate  resulted  in  coumarin  derivative  10.  Compounds  8  and  11  were 
prepared by a method reported in the literature [49,50]. 
3.3. Iron-Chelating Activity 
The  chelation  of  ferrous  ions  by  compound  7  was  estimated  using  a  modified  method  of  
Lopes et al. [51,52]. Ferrous ammonium sulfate was added to a solution containing 5% ammonium 
buffer and different concentrations of compound 7 (0.3, 1, and 3 mM). The final concentration of 
ferrous ammonium sulfate was 0.5 mM. Ferrozine was added to initiate the reaction, and the final 
concentration was 0.25 mM. The reaction mixture was incubated at room temperature for 15 min after 
being  shaken.  The  absorbance  of  the  solution  was  measured  at  562  nm  in  a  Helius  Alpha 
spectrophotometer (Unicam Instruments, Cambridge, UK). Deferoxamine was used as a control at a 
final concentration 30 µM. The higher the iron-chelating activity of a tested sample was, the lower the 
resulting ultraviolet absorbance. Therefore, the relative iron-chelating capacity was calculated as the 
percent decrease in absorbance of the test samples compared to the controls that lacked the test drugs.
 
3.4. 
1H-NMR Studies of Metal Chelation 
1H  NMR  studies  were  carried  out  on  a  Bruker  AC  400  spectrometer.  A  stock  solution  of  
7  (150  mM)  was  freshly  prepared  in  DMSO-d6.  Zinc  acetate  (300  mM)  was  prepared  in  D2O. 
Titrations  were  done  in  a  50/50  (v/v)  DMSO-d6/D2O  solvent  buffered  with  50  mM  Tris-HCl  at  
pH 7.20. The pH of the solutions was determined with a Corning pH meter (Corning, NY, USA) using 
a Sigma-Aldrich micro combination electrode (St. Louis, MO, USA). The pH meter readings for D2O 
were recorded as pH values, i.e., uncorrected for the effect of deuterium. 
   Int. J. Mol. Sci. 2011, 12                       
 
 
7070 
3.5. Absorption Spectra of Coumarin Derivatives 
Coumarin  derivatives  2–7  (0.1  mM)  were  prepared  in  methanol,  and  absorption  spectra  were 
measured on a UV/Vis Scanning Spectrophotometer (DU series 700, Beckman Coulter, CA, USA). 
3.6. Biological Assay 
3.6.1. Purification of Porcine γ-Crystallin 
Porcine  lenses  were  decapsulated  and  homogenized  in  buffer  containing  50  mM  Tris-HCl,  
0.1  M  NaCl,  5  mM  EDTA,  0.01%  β-mercaptoethanol,  and  0.02%  sodium  azide  (pH  8.0).  After 
centrifugation at 16,060× g for 30 min, the supernatant was collected. The supernatant was applied to a 
TSK HW-55(F) column (Tosoh Bioscience, Japan) and eluted at 25 mL/h. Five well-resolved peaks 
were obtained and identified as HMα-, α-, βH-, βL-, and γ-crystallins (Data not shown) based on their 
subunit  compositions  as  revealed  by  sodium  dodecylsulfate  polyacrylamide  gel  electrophoresis  
(SDS-PAGE)  [28,53,54].  Fractions  of  porcine  γ-crystallin  were  collected,  and  the  protein 
concentration was determined according to the Bradford method (BioRad Laboratories, USA). 
3.6.2. Turbidity Assays of γ-Crystallin under UVC Irradiation 
Photoaggregation of γ-crystallin (20–25 µM) was monitored in a buffer of 50 mM Tris-HCl and  
0.1 M NaCl at pH 8.0, in the absence or presence of coumarin derivatives. Sample solutions of 200 µL 
each were exposed to a UV lamp (254 nm) of Ultraviolet Crosslinker CL-1000 (Bulletin UVP-AB-114, 
USA). Turbidity changes represented by relative light-scattering intensities after irradiation for four 
hours were measured at 630 nm by an enzyme-linked immunosorbent assay (ELISA) reader. Four 
sample  solutions  were  used  in  the  experiment  for  each  condition.  The  percentage  of  suppression,  
(Iγ−Ic)/Iγ × 100%, was used to evaluate the anti-UVC activity, where Iγ is the intensity of scattered 
light for γ-crystallin without a compound, and Ic is the intensity of scattered light for γ-crystallin with 
a compound. SDS-PAGE (with 5% stacking and 12% resolving gels) was performed as previously 
reported [55]. Each well contained approximately 4 µg of porcine γ-crystallin. 
3.6.3. Protection of Supercoiled DNA from Strand Breakage by UVC Irradiation 
The activity of preventing photodegradation was evaluated by incubating compounds with DNA 
and irradiating them under UV light. Plasmid DNA (PUC 19) was incubated at 25 °C in water, with or 
without compound 6 or vitamin C. Sample solutions of 200 µL (0.0225 µg/µL PUC19) were each 
exposed to a UV lamp (254 nm) of Ultraviolet Crosslinker CL-1000 (Bulletin UVP-AB-114, USA), 
and samples were collected every 30 min. DNA samples were analyzed on 0.8% agarose gels. Each 
well contained approximately 450 µg of PUC19. 
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3.6.4. Fenton Reaction 
Crude porcine lens proteins were incubated with various Fenton solutions modified based on the 
method  of  Huang  et  al.  [56].  The  final  concentrations  of  Fe
2+  and  H2O2  in  Fenton  solutions  of 
experiments were 0.02 and 0.2 mM, respectively. The fluorescence emission spectra were immediately 
taken at room temperature and recorded with a Hitachi F-4500 FL fluorescence spectrophotometer 
excited with 295-nm light. The emission spectra were recorded at 300–400 nm using a light slit of  
5  nm  for  both  the  excitation  and  emission  modes.  Spectra  of  normal  lens  proteins  were  used  as 
baselines for calculating changes in the tryptophan fluorescence intensity. 
4. Conclusions  
We established an in vitro assay to screen compounds with anti-UV properties. Compound 7 was 
the most potent compound among these coumarin derivatives that suppressed turbidity induced by UV 
irradiation. The 5,7-dihydroxyl groups play important roles in maintaining the anti-UV activity of this 
compound. The phenyl group at position 4 and benzoyl group at position 6 of compound 7 are partially 
responsible for the anti-UV activity. It is reasonable that compounds with a phenolic hydroxyl group 
possess free radical-scavenging properties. Therefore, coumarin derivatives can protect γ-crystallin and 
DNA from free-radical damage produced by UVC irradiation. In addition to the free-radical-scavenging 
properties,  we  also  noted  the  UV-filtering  property  of  coumarin  derivatives.  The  human  lens  
absorbs most of the UV radiation at 300–400 nm. This absorption is largely performed by a group of  
low-molecular-weight fluorescent compounds, known as UV-filter compounds [57–59]. In order to 
evaluate the UV-filtering properties of coumarin derivatives, we measured the UV spectra of these 
compounds (Figure 6). The optical density at 254 nm of each compound was plotted in this figure. It is 
interesting that compounds with higher anti-UVC activities possess higher absorption at 254 nm. The 
only exception was compound 5, which showed low activity but high absorption. The low activity may 
have been due to the phenolic hydroxyl group’s inability to carry out the single-electron reduction  
of the p-cyanobenzoyl group, leading to an unstable free radical at position 6. Compound 7 was shown 
to possess the highest anti-UVC activity and best UV-filtering property at 254 nm. In addition, the 
iron-chelating activity gives compound 7 an additional potential application in iron-related cataracts. 
Increasing evidence relating iron to cataractogenesis includes reports of cataract formation following 
ocular siderosis from an iron foreign body in the lens [60–64]. The benefits of iron chelators are 
currently  being  investigated  for  limiting  iron-induced  oxidative  damage.  In  conclusion,  we  have 
developed a set of in vitro assays and 6-benzoyl-5,7-dihydroxy-4-phenyl-chromen-2-one (7) protected 
lens γ-crystallins against UVC insults and chelated metal via its structure of 6-CO and 5-OH on the 
benzopyrone ring. Further in vivo anti-cataractogenesis assay is warranted.  
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Figure 6. The relationship of UV absorbance of compounds and their anti-UV activity.  
(A)  The  absorption  spectra  of  compounds  2–7;  (B)  The  UV  absorbance  (254  nm)  of 
compounds 2–7; (C) The anti-UV activities of compounds 2–7 are shown in percentages of 
the suppression of turbidity. 
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